ATS Governance

HomeAboutATS Governance ▶ ATS Leadership
ATS Leadership

The ATS installed new officers to lead the Society for the 2020-2021 term. Each officer was sworn in on Tuesday, May 19, during the ATS 2020 Virtual Plenary Session.

Juan C. Celedón, MD, DrPH

Juan C. Celedón, MD, DrPH, ATSF, was installed as president for the 2020-21 term.

Dr. Celedón is the Niels K. Jerne Professor of Pediatrics and Medicine, and chief of the Division of Pediatric Pulmonary Medicine at the University of Pittsburgh School of Medicine.

Dr. Celedón earned a degree in medicine from Javeriana University in Colombia and a doctoral degree in public health from Harvard University. He completed a residency in Internal Medicine at Beth Israel Medical Center in New York, a Fellowship in Pulmonary and Critical Care Medicine at Brown University, and a Research Fellowship at the Channing Laboratory of Brigham and Women's Hospital and Harvard Medical School. In 2000, he joined the faculty at Harvard Medical School, rising to Associate Professor before joining the University of Pittsburgh in 2010.

Dr. Celedón's research has focused on asthma, COPD, and health disparities in airway diseases. His scientific contributions have been acknowledged through his election to the American Society for Clinical Investigation and the Association of American Physicians, as well as through the ATS Recognition Award for Scientific Accomplishments, among other honors. A devoted mentor, he was the first faculty member to ever receive both the Young Mentor Award and the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School.

The ATS has long been his professional home, and his vision for the Society is one of constant innovation and excellence in diversity.

2020 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.

 
Lynn Schnapp, MD

Lynn Schnapp, MD, ATSF, was installed as president-elect for the 2020-2021 term. Dr. Schnapp is the George R. and Elaine Love professor and chair of the Department of Medicine at the University of Wisconsin School of Medicine and Public Health. She is a faculty member in the division of Allergy, Pulmonary and Critical Care Medicine and is a graduate fellow of the Hedwig van Ameringen Executive Leadership in Academic Medicine Program for Women.

Dr. Schnapp became a member of the ATS in 1989. Since that time, she has been involved with a wide range of committees, working groups, task forces and assembly programs. As chair of the Respiratory, Cell and Molecular Biology Assembly, she served on the ATS Executive Board.

She received her BS from MIT, her MD and medicine residency training from the University of Pennsylvania, and her pulmonary and critical care fellowship training at UCSF, where she remained on faculty for several years before moving to Mount Sinai School of Medicine. She then moved to the University of Washington in 2000, where she became a professor. There, she directed the Respiratory Cell Molecular Biology Research Track and led the Career Development Core for the NIH Clinical and Translational Science Award. In 2013, Dr. Schnapp was recruited to the Medical University of South Carolina (MUSC) to assume the position of division chief before joining the Department of Medicine at the University of Wisconsin School of Medicine and Public Health in 2020.

Dr. Schnapp is an active clinician who is particularly passionate about developing the next generation of leaders and increasing the representation of women and underrepresented minorities in our field. Her mentee training record extends from high school students through junior faculty, and allied health professionals, many of whom now have faculty positions. Dr. Schnapp has received many honors for mentoring, including the ATS Elizabeth Rich Award, NIH Mid-Career Mentoring Award, UW School of Medicine Award for Mentoring, and Advancement of Women Faculty Award at MUSC.

2020 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.
 
Gregory P. Downey

Gregory P. Downey,  MD, ATSF, will serve as vice-president for the 2020-2021 term. He is a professor of medicine, pediatrics, and biomedical research at National Jewish Health where he also serves as executive vice president of Academic Affairs, and provost. He is also professor of medicine and immunology and microbiology and associate dean of the School of Medicine, at the University of Colorado in Denver.

Dr. Downey has been a member of the ATS since 1988. He has served on the AII Executive Committee and Board of Directors, and as chair of the Assembly on Allergy, Immunology and Inflammation. Dr. Downey has also served as a member of the Basic Science Core Committee and the MITT Committee, as well as deputy editor of the American Journal of Respiratory Cell and Molecular Biology.

He leads a basic and translational science research laboratory focused on mechanisms of lung injury, repair, and fibrosis. His research program has been funded by the National Institutes of Health, the Canadian Institutes of Health Research, and the U.S. Department of Defense for over 25 years. His contributions to research were recognized by an ATS Award for Scientific Accomplishments in 2010. He has also been the recipient of a Tier 1 Canada Research Chair in Respiration Sciences.

2020 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.

 
M. Patricia Rivera

M. Patricia Rivera, MD, ATSF, was installed as secretary-treasurer for the 2020-2021 term.

Dr. Rivera is a professor of medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina (UNC) at Chapel Hill. She received her medical degree from Stony Brook University School of Medicine and completed her training in internal medicine at Northshore University Hospital. She received her pulmonary fellowship training at Memorial Sloan-Kettering Cancer Hospital, where she also served as chief resident in the Department of Medicine. She received my critical care training at Northshore University Hospital.

In 1995, she joined the faculty at UNC and co-founded the first Multidisciplinary Thoracic Oncology Program in the country, a premier program that became the model for multidisciplinary care and defined the vital role pulmonologists play in the care of patients with thoracic malignancies. More recently, she founded the Multidisciplinary Lung Cancer Screening Program at UNC and she continues to direct both programs.

As part of NIH/NCI funded research, she co-developed and serves as co-investigator of the North Carolina Lung Screening Registry, a statewide initiative to examine the delivery, quality and outcomes of lung cancer screening and evaluate the extent to which disparities in lung cancer screening outcomes exist. Her ongoing funded research activities include a multi-institution pilot project exploring the presence of coronary artery calcification on lung cancer screening CT and downstream risk stratification and statin delivery, as well as exploring rural/urban disparities associated with biomarker testing in advanced lung cancer.

2020 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.

 
James Beck, MD

James Beck, MD, ATSF, was installed as immediate past-president for the 2020-2021 term. Dr. Beck is professor of medicine in the Division of Pulmonary Sciences and Critical Care at the University of Colorado, and vice-chair for Veterans Affairs in the University of Colorado's Department of Medicine.  He has been chief of medicine for the VA Eastern Colorado Health Care System since 2012.

The ATS has been a major component of Dr. Beck's professional identity since 1987. He has served as MTPI (now PI-TB) assembly chair, chair of the International Conference and Education Committees, and chair of the Planning and Evaluation Committee. He helped co-lead efforts to create a home for clinician-educators within ATS, assisting in the development of a new Section on Medical Education.  He  currently represents ATS in the Forum of International Respiratory Societies).

His research interests include HIV-related opportunistic infections and the emerging field of the lung microbiome. He was a principal investigator for the NHLBI's Lung HIV Microbiome Project. Dr. Beck's clinical achievements have been recognized by selection for Best Doctors in America annually since 1994. He is passionate about resident and fellow education and was elected to the University of Colorado's Academy of Medical Educators in 2014.  He serves as the Councilor for the University of Colorado's Chapter of Alpha Omega Alpha, the national medical honor society.

2020 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.